Stay updated on MiST: Multi-drug Phase II Clinical Trial
Sign up to get notified when there's something new on the MiST: Multi-drug Phase II Clinical Trial page.

Latest updates to the MiST: Multi-drug Phase II Clinical Trial page
- Check5 days agoChange DetectedThe study page continues to display an error instead of the clinical trial record; the temporary NIH terminology-transition banner is no longer shown.SummaryDifference1%

- Check12 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA sitewide banner announces NIH’s transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check26 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the study-record error page.SummaryDifference0.3%

- Check33 days agoChange DetectedThe footer now identifies the site release as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the study content with a generic error screen and site header/footer. This indicates restricted access to the page rather than changes to the study record text.SummaryDifference21%

Stay in the know with updates to MiST: Multi-drug Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MiST: Multi-drug Phase II Clinical Trial page.